In recent years, many mutations have been identified in leukemia cells, such as recurrent lesions in the nucleophosmin gene (NPM1), FLT3-ITD, CEBPA, TET2, etc. It has been demonstrated that the extensive genetic abnormalities play an important role in the diagnosis, risk assessment, and determination of the prognosis of patients. Here, NPM1 is linked to leukemia.